Tag: Patients
Search News
Blood test for prostate cancer
17th September 2019
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, in a study led by BCI’s Professor Yong-Jie Lu.
Read more
BRCA testing for higher risk group
13th September 2019
Researchers are calling for population-wide BRCA testing in the Jewish community after finding it to be more effective than current approaches, cost effective and to have a high satisfaction rate with those undergoing testing.
Read more
Blood Cancer Awareness Month 2019
1st September 2019
Today marks the start of Blood Cancer Awareness Month. Our researchers are committed to work to understand the biology of blood cancer and harness this knowledge to identify new treatment strategies to help those affected.
Read more
Understanding familial leukaemia
8th August 2019
In 2014, the charity Bloodwise awarded a 5-year programme grant to a team from Queen Mary University of London to support research to better understand the nature of the faulty genes responsible for an inherited/familial predisposition to MDS/AML.
Read more
2019 ASCO Annual Meeting
4th June 2019
Professor Peter Schmid, Lead of the Centre for Experimental Cancer Medicine at the Barts Cancer Institute, Queen Mary University of London, attended this year’s ASCO Annual Meeting and today presented updated survival data from the IMpassion130 trial.
Read more
AR alterations in prostate cancer
16th May 2019
Recent findings from a study published in JAMA Oncology have identified genetic markers within blood samples which may indicate whether patients with prostate cancer will respond to hormonal therapies. The study may represent an important step forward for the development of more personalised treatments for advanced prostate cancer.
Read more